{"title":"A Comparison of the Quality of Data, Assessed Using Query Rates, From Clinical Trials Conducted Across Developed Versus Emerging Global Regions","authors":"P. Desai, C. D. Anderson, W. Sietsema","doi":"10.1177/0092861512446807","DOIUrl":null,"url":null,"abstract":"With increasing globalization of clinical trials, there is a growing concern regarding the quality of data generated from clinical studies conducted in some of the emerging regions. This concern has not been comprehensively addressed thus far because there is limited public access to restricted databases. In this study, we utilized data from 26 large phase II/III trials conducted in multiple regions of the globe by members of the Association of Clinical Research Organization and compared query rates, one of the few measurable parameters of quality of clinical trials data, between different global regions. A query is generated when a discrepancy is noted between protocol or source data and the case report forms (CRFs). A resolution of such an inconsistency is necessitated, which may result in a database change. The studies included in our analyses were conducted at 4721 global sites enrolling 63,871 participants. Overall, the data set included 1.39 million queries, 7.5 million CRF pages, and 95 million data parameters. The number of queries for various regions was added for each trial and normalized to the number of CRF pages or to the number of CRF data parameters. The calculated mean query rates and database change rates were compared using parametric and nonparametric statistical approaches. None of these approaches revealed statistically significant differences in the query rates or the rate of database change when each region was compared to North America or Western Europe. Thus, a comparative assessment of query rates suggests that the quality of clinical trials conducted in emerging countries is consistent with those conducted in developed regions. Despite several limitations of our analyses and the multifaceted complexities of global clinical trials, our findings should alleviate some concerns regarding clinical studies conducted in emerging nations.","PeriodicalId":391574,"journal":{"name":"Drug information journal : DIJ / Drug Information Association","volume":"36 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2012-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug information journal : DIJ / Drug Information Association","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/0092861512446807","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6
Abstract
With increasing globalization of clinical trials, there is a growing concern regarding the quality of data generated from clinical studies conducted in some of the emerging regions. This concern has not been comprehensively addressed thus far because there is limited public access to restricted databases. In this study, we utilized data from 26 large phase II/III trials conducted in multiple regions of the globe by members of the Association of Clinical Research Organization and compared query rates, one of the few measurable parameters of quality of clinical trials data, between different global regions. A query is generated when a discrepancy is noted between protocol or source data and the case report forms (CRFs). A resolution of such an inconsistency is necessitated, which may result in a database change. The studies included in our analyses were conducted at 4721 global sites enrolling 63,871 participants. Overall, the data set included 1.39 million queries, 7.5 million CRF pages, and 95 million data parameters. The number of queries for various regions was added for each trial and normalized to the number of CRF pages or to the number of CRF data parameters. The calculated mean query rates and database change rates were compared using parametric and nonparametric statistical approaches. None of these approaches revealed statistically significant differences in the query rates or the rate of database change when each region was compared to North America or Western Europe. Thus, a comparative assessment of query rates suggests that the quality of clinical trials conducted in emerging countries is consistent with those conducted in developed regions. Despite several limitations of our analyses and the multifaceted complexities of global clinical trials, our findings should alleviate some concerns regarding clinical studies conducted in emerging nations.
随着临床试验日益全球化,人们越来越关注在一些新兴地区进行的临床研究产生的数据质量。到目前为止,这一问题尚未得到全面解决,因为公众对受限制的数据库的访问有限。在这项研究中,我们利用了临床研究组织协会(Association of Clinical Research Organization)成员在全球多个地区进行的26项大型II/III期试验的数据,并比较了全球不同地区之间的查询率(临床试验数据质量的少数可测量参数之一)。当注意到协议或源数据与病例报告表单(crf)之间存在差异时,将生成查询。需要解决这种不一致,这可能导致数据库更改。纳入我们分析的研究在全球4721个地点进行,共有63871名参与者。总的来说,该数据集包括139万个查询、750万个CRF页面和9500万个数据参数。为每个试验添加不同区域的查询数量,并将其归一化为CRF页面的数量或CRF数据参数的数量。使用参数和非参数统计方法比较计算出的平均查询率和数据库变化率。当将每个地区与北美或西欧进行比较时,这些方法都没有显示出查询率或数据库变更率在统计上的显著差异。因此,对查询率的比较评估表明,在新兴国家进行的临床试验的质量与在发达地区进行的临床试验的质量是一致的。尽管我们的分析存在一些局限性,而且全球临床试验具有多方面的复杂性,但我们的发现应该减轻人们对在新兴国家进行临床研究的一些担忧。